DOVA

Dova Pharmaceuticals News: DOVA Stock Skyrockets 38% on Sobi Deal

By William White, InvestorPlace Writer
Dova Pharmaceuticals (DOVA) news for Monday about a $915 million deal with Swedish Orphan Biovitrum has DOVA stock flying high.

4 Low-Priced Stocks Under $10 for 2019

By Aaron Levitt, InvestorPlace Contributor
Low-priced stocks can offer plenty of opportunity for risk-seeking investors. Here are four that have plenty of potential.

5 Biotech Stocks That Could Be the Next Amgen

By Aaron Levitt, InvestorPlace Contributor
Looking for the next big biotech stock? Skip the clinical ones and focus on those with approved drugs. Here are 5 biotech stocks to buy today.